Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6

被引:41
作者
Crook, T
Ludwig, RL
Marston, NJ
Willkomm, D
Vousden, KH
机构
[1] NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, FREDERICK, MD 21702 USA
[2] INST CANC RES, HADDOW LABS, SUTTON SM2 5NG, SURREY, ENGLAND
[3] UNIV LUBECK, D-23538 LUBECK, GERMANY
关键词
D O I
10.1006/viro.1996.0115
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The activity of the p53 tumor suppressor protein is regulated, at least in part, through the stability of the protein. p53 degradation in normal cells is controlled by ubiquitin-dependent proteolysis, and activation of p53 following DNA damage is associated with an increase in the stability of the protein. The human papillomavirus-encoded E6 protein abrogates p53 function by targeting it for rapid degradation, also through the ubiquitin pathway. Although the p53 protein is ubiquitinated following interaction with E6, we show here that none of the lysine residues within p53 are specifically required for E6-targeted degradation. Mutation of lysine residues within the C-terminus of p53 resulted in resistance to E6-mediated degradation in vitro, although the ability of the two proteins to form a complex was not affected. The same mutant was efficiently targeted for degradation in cells, however, illustrating a lack of correlation between the in vitro and the in vivo assays. (C) 1996 Academic Press, Inc.
引用
收藏
页码:285 / 292
页数:8
相关论文
共 49 条
  • [1] ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION
    BANKS, L
    MATLASHEWSKI, G
    CRAWFORD, L
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03): : 529 - 534
  • [2] CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS
    CHO, YJ
    GORINA, S
    JEFFREY, PD
    PAVLETICH, NP
    [J]. SCIENCE, 1994, 265 (5170) : 346 - 355
  • [3] ACCUMULATION OF P53 IN A MUTANT-CELL LINE DEFECTIVE IN THE UBIQUITIN PATHWAY
    CHOWDARY, DR
    DERMODY, JJ
    JHA, KK
    OZER, HL
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) : 1997 - 2003
  • [4] DEGRADATION OF NUCLEAR ONCOPROTEINS BY THE UBIQUITIN SYSTEM INVITRO
    CIECHANOVER, A
    DIGIUSEPPE, JA
    BERCOVICH, B
    ORIAN, A
    RICHTER, JD
    SCHWARTZ, AL
    BRODEUR, GM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (01) : 139 - 143
  • [5] CIECHANOVER A, 1994, J BIOL CHEM, V269, P9582
  • [6] THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY
    CIECHANOVER, A
    [J]. CELL, 1994, 79 (01) : 13 - 21
  • [7] MODULATION OF IMMORTALIZING PROPERTIES OF HUMAN PAPILLOMAVIRUS TYPE-16 E7 BY P53 EXPRESSION
    CROOK, T
    FISHER, C
    VOUSDEN, KH
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (01) : 505 - 510
  • [8] PROPERTIES OF P53 MUTATIONS DETECTED IN PRIMARY AND SECONDARY CERVICAL CANCERS SUGGEST MECHANISMS OF METASTASIS AND INVOLVEMENT OF ENVIRONMENTAL CARCINOGENS
    CROOK, T
    VOUSDEN, KH
    [J]. EMBO JOURNAL, 1992, 11 (11) : 3935 - 3940
  • [9] DEGRADATION OF P53 CAN BE TARGETED BY HPV E6 SEQUENCES DISTINCT FROM THOSE REQUIRED FOR P53 BINDING AND TRANSACTIVATION
    CROOK, T
    TIDY, JA
    VOUSDEN, KH
    [J]. CELL, 1991, 67 (03) : 547 - 556
  • [10] CROOK T, 1994, ONCOGENE, V9, P1225